home All News open_in_new Full Article

MEDIPAL HOLDINGS and JCR Pharmaceuticals Sign Global Licensing and Japan Co

MEDIPAL HOLDINGS and JCR Pharmaceuticals Sign Global Licensing and Japan Co-Development Agreement for JR-479, a Novel Therapy for GM2 Gangliosidosis  Business Wire


today 1 week ago attach_file Other



ID: 682745673
Add Watch Country

arrow_drop_down